Evolving interpretable structure - Activity relationships. 1. Reduced graph queries

Journal of Chemical Information and Modeling

Volumn 48, Issue 8, 2008, Pages 1543-1557

  Birchall, Kristian ^a   Gillet, Valerie J ^a   Harper, Gavin ^b   Pickett, Stephen D ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GRAPH ALGORITHMS; LEARNING SYSTEMS;

ACTIVE COMPOUNDS; ENCODING STRUCTURE; HETEROGENEOUS COMPOUNDS; HIGH-THROUGHPUT SCREENING; INDEPENDENT SET; MACHINE LEARNING METHODS; SCREENING DATA; STRUCTURE ACTIVITY RELATIONSHIPS;

DATA MINING;

SEROTONIN 1A RECEPTOR;

ALGORITHM; ARTICLE; CHROMOSOME; COMBINATORIAL CHEMISTRY; DRUG POTENTIATION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PHENOTYPE; STRUCTURE ACTIVITY RELATION;

ALGORITHMS; CHROMOSOMES; COMBINATORIAL CHEMISTRY TECHNIQUES; HUMANS; PHENOTYPE; RECEPTOR, SEROTONIN, 5-HT1A; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 52049115881     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci8000502     Document Type: Article

References (38)

1. Harper, G.; Pickett, S. D. Methods for mining HTS data. Drug Discovery Today 2006, 11, 694-699.
2. Saeh, J. C.; Lyne, P. D.; Takasaki, B. K.; Cosgrove, D. A. Lead hopping using SVM and 3D pharmacophore fingerprints. J. Chem. Inf. Model. 2005, 45, 1122-1133.
3. Rogers, D.; Brown, R. D.; Hahn, M. Using extended-connectivity fingerprints with Laplacian-modified Bayesian analysis in highthroughput screening follow-up. J. Biomol. Screening 2005, 10, 682-686.
4. Chen, B. N.; Harrison, R. F.; Pasupa, K.; Willett, P.; Wilton, D. J.; Wood, D. J.; Lewell, X. Q. Virtual screening using binary kernel discrimination: Effect of noisy training data and the optimization of performance. J. Chem. Inf. Model. 2006, 46, 478-486.
5. Glick, M.; Jenkins, J. L.; Nettles, J. H.; Hitchings, H.; Davies, J. W. Enrichment of high-throughput screening data with increasing levels of noise using support vector machines, recursive partitioning, and Laplacian-modified naïve Bayesian classifiers. J. Chem. Inf. Model. 2006, 46, 193-200.
6. Cannon, E. O.; Amini, A.; Bender, A.; Sternberg, M. J. E.; Muggleton, S. H.; Glen, R. C.; Mitchell, J. B. O. Support vector inductive logic programming outperforms the naïve bayes classifier and inductive logic programming for the classification of bioactive chemical compounds. J. Comput.-Aided Mol. Des. 2007, 21, 269-280.
7. Plewczynski, D.; Spieser, S. A. H.; Koch, U. Assessing different classification methods for virtual screening. J. Chem. Inf. Model. 2006, 46, 1098-1106.
8. van Rhee, A. M. Use of recursion forests in the sequential screening process: Consensus selection by multiple recursion trees. J. Chem. Inf. Comput. Sci. 2003, 43, 941-948.
9. Bruce, C. L.; Melville, J. L.; Pickett, S. D.; Hirst, J. D. Contemporary QSAR classifiers compared. J. Chem. Inf. Model. 2007, 47, 219-227.
10. Gillet, V. J.; Willett, P.; Bradshaw, J. Similarity searching using reduced graphs. J. Chem. Inf. Comput. Sci. 2003, 43, 338-345.
11. Barker, E. J.; Cosgrove, D. A.; Gardiner, E. J.; Gillet, V. J.; Kitts, P.; Willett, P. Scaffold-hopping using clique detection applied to reduced graphs. J. Chem. Inf. Model. 2006, 46, 503-511.
12. Gardiner, E. J.; Gillet, V. J.; Willett, P.; Cosgrove, D. A. Representing clusters using a maximum common edge substructure algorithm applied to reduced graphs and molecular graphs. J. Chem. Inf. Model. 2006, 47, 354-366.
13. Harper, G.; Bravi, G. S.; Pickett, S. D.; Hussain, J.; Green, D. V. S. The reduced graph descriptor in virtual screening and data-driven clustering of high-throughput screening data. J. Chem. Inf. Comput. Sei. 2004, 44, 2145-2156.
14. Takahashi, Y.; Sukekawa, M.; Sasaki, S. Automatic identification of molecular similarity using reduced-graph representation of chemical-structure. J. Chem. Inf. Comput. Sci. 1992, 32, 639-643.
15. Rarey, M.; Dixon, J. S. Feature trees: A new molecular similarity measure based on tree matching. J. Comput.-Aided Mol. Des. 1998, 12, 471-190.
16. Steifl, N.; Watson, I. A.; Baumann, K.; Zaliani, A. Erg: 2D pharmacophore descriptions for scaffold hopping. J. Chem. Inf. Model. 2006, 46, 208-220.
17. Bemis, G. W.; Murcko, M. A. The properties of known drugs. 1. Molecular frameworks. J. Med. Chem. 1996, 39, 28872893.
18. Daylight Daylight Chemical Information Systems, Inc., 120 Vantis -Suite 550, Aliso Viejo, CA 92656, U.S.A. www.daylight.com at http:// www.daylight.com.
19. Globus, A.; Lawton, J.; Wipke, T. Automated molecular design using evolutionary techniques. Nanotechnology 1999, 10, 290-299.
20. Nachbar, R. B. Molecular evolution: Automated manipulation of hierarchical chemical topology and its application to average molecular structures. Genetic Programming Evolvable Machines 2000, 1, 57-94.
21. Brown, N.; McKay, B.; Gasteiger, J. The de novo design of median molecules within a property range of interest. J. Comput.-Aided Mol. Des. 2004, 18, 761-771.
22. Lameijer, E. W.; Kok, J. N.; Back, T.; Ijzerman, A. P. The molecule evoluator. An interactive evolutionary algorithm for the design of druglike molecules. J. Chem. Inf. Model. 2006, 46, 545-552.
23. Gusfield, D. Algorithms on strings, trees and sequences: Computer science and computational biology; Cambridge University Press: 1997.
24. van Rijsbergen, C. J. Information retrieval; Butterworth: London, 1979.
25. MDL Information Systems Inc. 2440 Camino Ramon, Suite 300, San Ramon, CA 94583.
26. Hert, J.; Willett, P.; Wilton, D. J.; Acklin, P.; Azzaoui, K.; Jacoby, E.; Schuffenhauer, A. Comparison of fingerprint-based methods for virtual screening using multiple bioactive reference structures. J. Chem. Inf. Comput. Sci. 2004, 44, 1177-1185.
27. Zlokarnik, G.; Grootenhuis, P. D. J.; Watson, J. B. High throughput p450 inhibition screens in early drug discovery. Drug Discovery Today 2005, 10, 1443-1450.
28. Sanguinetti, M. C.; Tristani-Firouzi, M. hERG potassium channels and cardiac arrhythmia. Nature 2006, 440, 463-469.
29. Birchall, K.; Gillet, V. J.; Harper, G.; Pickett, S. D. Training similarity measures for specific activities: Application to reduced graphs. J. Chem. Inf. Model. 2006, 46, 577-586.
30. Hert, J.; Willett, P.; Wilton, D. J.; Acklin, P.; Azzaoui, K.; Jacoby, E.; Schuffenhauer, A. New methods for ligand-based virtual screening: Use of data fusion and machine learning to enhance the effectiveness of similarity searching. J. Chem. Inf. Model. 2006, 46, 462-470.
31. Dellaria, J. F.; Maki, R. G.; Bopp, B. A.; Cohen, J.; Kleinen, H. D.; Luly, J. R.; Merits, I.; Plattner, J. J.; Stein, H. H. Optimization and invivo evaluations of a series of small, potent, and specific renin inhibitors containing a novel leu-val replacement. J. Med. Chem. 1987, 30, 2137-2144.
32. Chilmonczyk, Z. Ligand-5-ht1a receptor interaction. Il Farmaco 2000, 55, 191-193.
33. Birchall, K.; Gillet, V. J.; Harper, G.; Pickett, S. D. Evolving interpretable structure-activity relationship models. 2. Using multi-objective optimization to derive multiple models. J. Chem. Inf. Model. 2008, 48, 1558-1570.
34. Song, M.; Clark, M. Development and evaluation of an in silico model for hERG binding. J. Chem. Inf. Model. 2006, 46, 392-400.
35. Aronov, A. M.; Goldman, B. B. A model for identifying hERG K+ channel blockers. Bioorg. Med. Chem. 2004, 12, 2307-2315.
36. Wolff, T.; Distlerath, L. M.; Worthington, M. T.; Groopman, J. D.; Hammons, G. J.; Kadlubar, F. F.; Prough, R. A.; Martin, M. V.; Guengerich, F. P. Substrate-specificity of human-liver cytochromep-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling. Cancer Res. 1985, 45, 2116-2122.
37. Ekins, S.; Bravi, G.; Binkley, S.; Gillespie, J. S.; Ring, B. J.; Wikel, J. H.; Wrighton, S. A. Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors. Pharmacogenetics 1999, P, 477-489.
38. Chohan, K. K.; Paine, S. W.; Mistry, J.; Barton, P.; Davis, A. M. A rapid computational filter for cytochrome p450 1A2 inhibition potential of compound libraries. J. Med. Chem. 2005, 48, 5154-5161.